key: cord-0888567-slyx32st authors: Rossi, Tommaso; Novi, Giovanni; D'Agostino, Isabella; di Cello, Luca; Soldati, Maria Romana; Telani, Serena; Ripandelli, Guido title: Bilateral optic neuritis as the presenting sign of post SARS-CoV-2 acute disseminated encephalomyelitis date: 2022-02-04 journal: Am J Ophthalmol Case Rep DOI: 10.1016/j.ajoc.2022.101273 sha: c95d709cdb2ae72bf26f60d947e9555d22ca0df8 doc_id: 888567 cord_uid: slyx32st PURPOSE: to report a case of Acute Disseminated EncephaloMyelitis (ADEM) occurring after documented SARS-Cov2 infection and flu-like disease. OBSERVATION: A 59-years-old woman presented with progressive visual loss and right leg paresthesia started 6 days earlier when CT scan excluded abnormalities. Visual acuity was OU hand motion with bilateral slow pupillary response and unremarkable ocular extrinsic motility while visual field testing showed diffuse bilateral sensitivity reduction. The patient had also right leg paresthesia and reported a 2-weeks flu-like syndrome 15 days earlier, with nausea, diarrhea, anosmia, ageusia, cough. Brain Magnetic Resonance Imaging revealed bilateral optic nerve enhancement, multiple brain and spine lesions. SARS-CoV-2 PCR tested negative on nasal swab and positive on cerebrospinal fluid. Patient's serum tested positive for anti-SARS-CoV-2 IgG, negative for anti-aquaporin-4 and anti-myelin oligodendrocyte glycoprotein antibodies. A diagnosis of suspect ADEM post SARS-CoV-2 infection was made and treatment with high dose intravenous methylprednisolone (with subsequent prednisone tapering) and immunoglobulins started. Ten days later vision improved to 20/30 RE and 20/25 LE and 3 months later to 20/20. CONCLUSION: and Importance: ADEM may ensue after SARS-CoV-2 virus infection. High suspicious index and prompt aggressive treatment may result in complete vision restauration. [Instructions: Please check all applicable boxes and provide additional information as requested.] Potential conflict of interest exists: We wish to draw the attention of the Editor to the following facts, which may be considered as potential conflicts of interest, and to significant financial contributions to this work: The nature of potential conflict of interest is described below: X No conflict of interest exists. We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. Funding was received for this work. All of the sources of funding for the work described in this publication are acknowledged below: [List funding sources and their role in study design, data analysis, and result interpretation] X No funding was received for this work. X We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property. X We further confirm that any aspect of the work covered in this manuscript that has involved human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. IRB approval was obtained (required for studies and series of 3 or more cases). N/A Written consent to publish potentially identifying information, such as details or the case and photographs, was obtained from the patient(s) or their legal guardian(s). N/A The International Committee of Medical Journal Editors (ICMJE) recommends that authorship be based on the following four criteria: 1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND 2. Drafting the work or revising it critically for important intellectual content; AND 3. Final approval of the version to be published; AND 4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. For more information on authorship, please see http://www.icmje.org/recommendations/browse/roles-andresponsibilities/defining-the-role-of-authors-and-contributors.html#two. X All listed authors meet the ICMJE criteria. We attest that all authors contributed significantly to the creation of this manuscript, each having fulfilled criteria as established by the ICMJE. One or more listed authors do(es) not meet the ICMJE criteria. We believe these individuals should be listed as authors because: J o u r n a l P r e -p r o o f X We confirm that the manuscript has been read and approved by all named authors. X We confirm that the order of authors listed in the manuscript has been approved by all named authors. The Corresponding Author declared on the title page of the manuscript is: X This author submitted this manuscript using his/her account in EVISE. X We understand that this Corresponding Author is the sole contact for the Editorial process (including EVISE and direct communications with the office). He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. X We confirm that the email address shown below is accessible by the Corresponding Author, is the address to which Corresponding Author's EVISE account is linked, and has been configured to accept email from the editorial office of American Journal of Ophthalmology Case Reports: Someone other than the Corresponding Author declared above submitted this manuscript from his/her account in EVISE: Acute Disseminated Encephalomyelitis X We understand that this author is the sole contact for the Editorial process (including EVISE and direct communications with the office). He/she is responsible for communicating with the other authors, including the Corresponding Author, about progress, submissions of revisions and final approval of proofs. We the undersigned agree with all of the above. A 59-year-old woman presented with 6-day history of bilateral painful, severe vision loss and right leg paresthesia one month following flu-like syndrome, anosmia, ageusia, cough, and diarrhea. Medical history included vitiligo, Hashimoto's thyroiditis and Monoclonal Gammopathy of Undetermined Significance diagnosed 3 years earlier managed through clinical follow-up. On presentation visual acuity was hand motion in both eyes, pupillary light responses were sluggish in both eyes with no relative afferent pupillary defect. Eye movement was full but associated with pain in all directions of gaze. Static perimetry revealed severe visual field defect in both eyes and colour testing proved impossible. Anterior and posterior segment examination, including optic nerves, was unremarkable as well as and ocular coherence tomography. Neurological examination showed ageusia with anosmia, irritability, headache, and a sensorymotor thoracic spinal syndrome with lower-limbs left-sided hyperreflexia with Babinski sign and right-sided sensory impairment. Neurological symptoms and signs were highly suggestive of encephalopathy with optic nerves and spinal cord involvement. The patient reported a flu-like syndrome lasting two weeks with nausea, diarrhea, anosmia, ageusia, cough (without dyspnoea), that started in about a month earlier and resolved after 15 days, except for anosmia and ageusia that persisted. She also referred right limb paresthesia starting 4 days earlier that she imputed to her long standing slipped L5-S1 disc. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome Central nervous system manifestations of COVID-19: A systematic review Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis A first case of meningitis/encephalitis associated with SARS-Coronavirus-2